Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 3/2014

01-09-2014

Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009–2010

Authors: Heather P. Tarleton, Suzanne Ryan-Ibarra, Marta Induni

Published in: Journal of Cancer Survivorship | Issue 3/2014

Login to get access

Abstract

Purpose

The California Behavioral Risk Factor Surveillance System estimates that 56.6 % of cancer survivors report ever being diagnosed with a chronic disease. Few studies have assessed potential variability in comorbidity by cancer type.

Methods

We used data collected from a representative sample of adult participants in the 2009 and 2010 California Behavioral Risk Factor Surveillance System (n = 18,807). Chronic diseases were examined with cancer survivorship in case/non-case and case/case analyses. Prevalence ratios (PR) and corresponding 95 % confidence intervals (95 % CI) were estimated using Cox proportional hazards models, with adjustment on race, sex, age, education, smoking, and drinking.

Results

Obesity was associated with gynecological cancers (PR 1.74; 95 % CI 1.26–2.41), and being overweight was associated with gynecological (PR 1.40; 95 % CI 1.05–1.86) and urinary (PR 2.19; 95 % CI 1.21–3.95) cancers. Arthritis was associated with infection-related (PR 1.78; 95 % CI 1.12–2.83) and hormone-related (PR 1.20; 95 % CI 1.01–1.42) cancers. Asthma was associated with infection- (PR 2.26; 95 % CI 1.49–3.43), hormone- (PR 1.46; 95 % CI 1.21–1.77), and tobacco- (PR 1.86; 95 % CI 1.25–2.77) related cancers. Chronic obstructive pulmonary disease (COPD) was associated with infection- (PR 2.16; 95 % CI 1.22–3.83) and tobacco-related (PR 2.24; 95 % CI 1.37–3.66) cancers and with gynecological cancers (PR 1.60; 95 % 1.00–2.56).

Conclusions

This is the first study to examine chronic disease burden among cancer survivors in California. Our findings suggest that the chronic disease burden varies by cancer etiology.

Implications for Cancer Survivors

A clear need has emerged for future biological and epidemiological studies of the interaction between chronic disease and cancer etiology in survivors.
Appendix
Available only for authorised users
Literature
1.
Dowling EC, Chawla N, Forsythe LP, de Moor J, McNeel T, Rozjabek HM, et al. Lost productivity and burden of illness in cancer survivors with and without other chronic conditions. Cancer. 2013;119(18):3393–401.CrossRefPubMed
2.
Fairley TL, Hawk H, Pierre S. Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: data use for comprehensive cancer control. Prev Chronic Dis. 2010;7(1):A09.PubMedCentralPubMed
3.
Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Survivorship: Res Pract. 2013;7(2):253–61.CrossRef
4.
Reyes-Gibby CC, Anderson KO, Morrow PK, Shete S, Hassan S. Depressive symptoms and health-related quality of life in breast cancer survivors. J Womens Health (Larchmt). 2012;21(3):311–8.CrossRef
5.
Craike MJ, Livingston PM, Botti M. An exploratory study of the factors that influence physical activity for prostate cancer survivors. Support Care Cancer. 2011;19(7):1019–28.CrossRefPubMed
6.
Stevinson C, Tonkin K, Capstick V, Schepansky A, Ladha AB, Valance JK, et al. A population-based study of the determinants of physical activity in ovarian cancer survivors. J Phys Act Health. 2009;6(3):339–46.PubMed
7.
Schootman M, Aft R, Jeffe DB. An evaluation of lower-body functional limitations among long-term survivors of 11 different types of cancers. Cancer. 2009;115(22):5329–38.PubMedCentralCrossRefPubMed
8.
Anzueto A. Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences. Am J Med Sci. 2010;340(4):309–18.CrossRefPubMed
9.
Haselkorn T, Chen H, Miller DP, Fish JE, Peters SP, Weiss ST, et al. Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) study. Ann Allergy Asthma Immunol. 2010;104(6):471–7.CrossRefPubMed
10.
Shi Q, Smith TG, Michonski JD, Stein KD, Kaw C, Cleeland CS. Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society’s Studies of Cancer Survivors. Cancer. 2011;117(12):2779–90.PubMedCentralCrossRefPubMed
11.
Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control: CCC. 2013;24(1):61–9.PubMedCentralCrossRefPubMed
12.
Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res: BCR. 2011;13(3):R64.PubMedCentralCrossRefPubMed
13.
Blanchard CM, Stein K, Courneya KS. Body mass index, physical activity, and health-related quality of life in cancer survivors. Med Sci Sports Exerc. 2010;42(4):665–71.CrossRefPubMed
14.
Buffart LM, Thong MS, Schep G, Chinapaw MJ, Brug J, van de Poll-Franse LV. Self-reported physical activity: its correlates and relationship with health-related quality of life in a large cohort of colorectal cancer survivors. PLoS One. 2012;7(5):e36164.PubMedCentralCrossRefPubMed
15.
Courneya KS, Katzmarzyk PT, Bacon E. Physical activity and obesity in Canadian cancer survivors: population-based estimates from the 2005 Canadian Community Health Survey. Cancer. 2008;112(11):2475–82.CrossRefPubMed
16.
Ji J, Liu X, Sundquist K, Sundquist J. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford). 2011;50(8):1513–8.CrossRef
17.
18.
Brown DW, Young KE, Anda RF, Giles WH. Asthma and risk of death from lung cancer: NHANES II Mortality Study. J Asthma. 2005;42(7):597–600.CrossRefPubMed
19.
Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD. Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011;13(3):R64.PubMedCentralCrossRefPubMed
20.
Ahern TP, Lash TL, Thwin SS, Silliman RA. Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors. Med Care. 2009;47(1):73–9.PubMedCentralCrossRefPubMed
21.
Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE, Mukherjee P. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res. 2009;11(4):R56.PubMedCentralCrossRefPubMed
22.
Girones R, Torregrosa D, Diaz-Beveridge R. Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience. Crit Rev Oncol Hematol. 2010;73(3):236–45.CrossRefPubMed
23.
Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–86.CrossRefPubMed
24.
Ji GY, Jin LB, Wang RJ, Bai Y, Yao ZX, Lu LJ, et al. Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment. Med Oncol. 2013;30(3):687.CrossRefPubMed
25.
Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1403–9.PubMedCentralCrossRefPubMed
26.
Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br J Cancer. 2013;108(1):188–92.PubMedCentralCrossRefPubMed
27.
Huertas A, Palange P. COPD: a multifactorial systemic disease. Ther Adv Respir Dis. 2011;5(3):217–24.CrossRefPubMed
28.
Mackay AJ, Hurst JR. COPD exacerbations: causes, prevention, and treatment. Med Clin North Am. 2012;96(4):789–809.CrossRefPubMed
29.
Boffetta P, Ye W, Boman G. Nyren: lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J. 2002;19(1):127–33.CrossRefPubMed
30.
Garcia Sanz MT, Gonzalez Barcala FJ, Alvarez Dobano JM, Valdes Cuadrado L. Asthma and risk of lung cancer. Clin Transl Oncol. 2011;13(10):728–30.CrossRefPubMed
31.
Gonzalez-Perez A, Fernandez-Vidaurre C, Rueda A, Rivero E, Garcia Rodriguez LA. Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf. 2006;15(2):131–8.CrossRefPubMed
32.
Rosenberger A, Bickeboller H, McCormack V, Brenner DR, Duell EJ, Tjonneland A, et al. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Carcinogenesis. 2012;33(3):587–97.PubMedCentralCrossRefPubMed
33.
El-Zein M, Parent ME, Ka K, Siemiatycki J, St-Pierre Y, Rousseau MC. History of asthma or eczema and cancer risk among men: a population-based case-control study in Montreal, Quebec, Canada. Ann Allergy Asthma Immunol. 2010;104(5):378–84.CrossRefPubMed
34.
Elmasri WM, Tran TH, Mulla ZD. A case-control study of asthma and ovarian cancer. Arch Environ Occup Health. 2010;65(2):101–5.CrossRefPubMed
35.
Lowcock EC, Cotterchio M, Ahmad N. Association between allergies, asthma, and breast cancer risk among women in Ontario. Canada: Cancer Causes Control; 2013.
36.
Severi G, Baglietto L, Muller DC, English DR, Jenkins MA, Abramson MJ, et al. Asthma, asthma medications, and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2318–24.CrossRefPubMed
37.
Chen YJ, Chang YT, Wang CB, Wu CY. The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan. Arthritis Rheum. 2011;63(2):352–8.CrossRefPubMed
38.
Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003;48(4):963–70.CrossRefPubMed
39.
Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst. 1993;85(4):307–11.CrossRefPubMed
40.
Hemminki K, Li X, Sundquist K, Sundquist J. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford). 2008;47(5):698–701.CrossRef
41.
Khurana R, Wolf R, Berney S, Caldito G, Hayat S, Berney SM. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheumatol. 2008;35(9):1704–8.PubMed
42.
Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control. 2009;20(6):1001–10.PubMedCentralCrossRefPubMed
43.
Das Roy L, Curry JM, Sahraei M, Besmer DM, Kidiyoor A, Gruber HE, et al. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling. Breast Cancer Res. 2013;15(2):R32.CrossRefPubMed
44.
Roy LD, Ghosh S, Pathangey LB, Tinder TL, Gruber HE, Mukherjee P. Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer. BMC Cancer. 2011;11:365.PubMedCentralCrossRefPubMed
45.
Barash H, R Gross E, Edrei Y, Ella E, Israel A, Cohen I, et al. Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks. Proc Natl Acad Sci U S A. 2010;107(5):2207–12.PubMedCentralCrossRefPubMed
46.
Fillon M. Details linking chronic inflammation and cancer continue to emerge. J Natl Cancer Inst. 2013;105(8):509–10.CrossRefPubMed
47.
Hannelien V, Karel G, Jo VD, Sofie S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta. 2012;1825(1):117–29.PubMed
48.
Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009;15(4):303–7.CrossRefPubMed
49.
McKay CJ, Glen P, McMillan DC. Chronic inflammation and pancreatic cancer. Best Pract Res Clin Gastroenterol. 2008;22(1):65–73.CrossRefPubMed
50.
51.
52.
53.
Anand S, Chertow GM, Johansen KL, Grimes B, Kurella Tamura M, Dalrymple LS, et al. Association of self-reported physical activity with laboratory markers of nutrition and inflammation: the Comprehensive Dialysis Study. J Ren Nutr. 2011;21(6):429–37.PubMedCentralCrossRefPubMed
54.
Autenrieth C, Schneider A, Doring A, Meisinger C, Herder C, Koenig W, et al. Association between different domains of physical activity and markers of inflammation. Med Sci Sports Exerc. 2009;41(9):1706–13.CrossRefPubMed
55.
Ertek S, Cicero A. Impact of physical activity on inflammation: effects on cardiovascular disease risk and other inflammatory conditions. Arch Med Sci. 2012;8(5):794–804.PubMedCentralCrossRefPubMed
56.
Hamer M, Steptoe A. Walking, vigorous physical activity, and markers of hemostasis and inflammation in healthy men and women. Scand J Med Sci Sports. 2008;18(6):736–41.CrossRefPubMed
57.
Jennersjo P, Ludvigsson J, Lanne T, Nystrom FH, Ernerudh J, Ostgren CJ. Pedometer-determined physical activity is linked to low systemic inflammation and low arterial stiffness in type 2 diabetes. Diabet Med. 2012;29(9):1119–25.CrossRefPubMed
58.
Lavie CJ, Church TS, Milani RV, Earnest CP. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation. J Cardiopulm Rehabil Prev. 2011;31(3):137–45.CrossRefPubMed
59.
Lee IM, Sesso HD, Ridker PM, Mouton CP, Stefanick ML, Manson JE. Physical activity and inflammation in a multiethnic cohort of women. Med Sci Sports Exerc. 2012;44(6):1088–96.CrossRefPubMed
60.
Lin CY, Chen PC, Kuo HK, Lin LY, Lin JW, Hwang JJ. Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999-2002. Nutr Metab Cardiovasc Dis. 2010;20(10):713–9.CrossRefPubMed
61.
Lujan HL, Dicarlo SE. Physical activity, by enhancing parasympathetic tone and activating the cholinergic anti-inflammatory pathway, is a therapeutic strategy to restrain chronic inflammation and prevent many chronic diseases. Med Hypotheses. 2013;80(5):548–52.CrossRefPubMed
62.
Stefanov T, Temelkova-Kurktschiev T, Koehler C, Henkel E, Schaper F, Hanefeld M. Association of physical activity with insulin resistance, subclinical inflammation, coagulation, and fibrinolytic biomarkers among population at high risk for type 2 diabetes. Folia Med (Plovdiv). 2012;54(2):32–9.
63.
Friedenreich CM, Neilson HK, Lynch BM. State of the epidemiological evidence on physical activity and cancer prevention. Eur J Cancer. 2010;46(14):2593–604.CrossRefPubMed
64.
Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219–29.PubMedCentralCrossRefPubMed
65.
Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(11):815–40.PubMedCentralCrossRefPubMed
66.
Sternfeld B, Weltzien E, Quesenberry Jr CP, Castillo AL, Kwan M, Slattery ML, et al. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):87–95.PubMedCentralCrossRefPubMed
67.
Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121–7.CrossRefPubMed
68.
Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol: Off J Am Soc Clin Oncol. 2010;28(26):4058–65.CrossRef
69.
Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N. Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003-2006). Cancer Causes Control. 2010;21(2):283–8.CrossRefPubMed
70.
Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, et al. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1468–73.CrossRefPubMed
71.
Siegel EM, Ulrich CM, Poole EM, Holmes RS, Jacobsen PB, Shibata D. The effects of obesity and obesity-related conditions on colorectal cancer prognosis. Cancer Control. 2010;17(1):52–7.PubMed
72.
Underwood JM, Townsend JS, Stewart SL, Buchannan N, Ekwueme DU, Hawkins NA, et al. Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ. 2012;61(1):1–23.PubMed
73.
Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr. 2010;92(3):471–90.CrossRefPubMed
74.
Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med. 1985;78(1A):29–32.CrossRefPubMed
75.
Stevenson CS, Birrell MA. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol Ther. 2011;130(2):93–105.CrossRefPubMed
76.
Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, et al. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer. 2012;130(5):1160–7.CrossRefPubMed
77.
78.
Turner MC, Chen Y, Krewski D, Ghadirian P, Thun MJ, Calle EE. Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol. 2005;162(3):212–21.CrossRefPubMed
79.
Jain M, Townsend RR. Chemotherapy agents and hypertension: a focus on angiogenesis blockade. Curr Hypertens Rep. 2007;9(4):320–8.CrossRefPubMed
80.
Eakin EG, Youlden DR, Baade PD, Lawler SP, Reeves MM, Heyworth JS, et al. Health status of long-term cancer survivors: results from an Australian population-based sample. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1969–76.CrossRefPubMed
81.
Mols F, Thong MS, Vreugdenhil G, van de Poll-Franse LV. Long-term cancer survivors experience work changes after diagnosis: results of a population-based study. Psychooncology. 2009;18(12):1252–60.CrossRefPubMed
82.
Sehl M, Lu X, Silliman R, Ganz PA. Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women. J Cancer Surviv. 2013;7(1):20–31.PubMedCentralCrossRefPubMed
83.
Trentham-Dietz A, Remington PL, Moinpour CM, Hampton JM, Sapp AL, Newcomb PA. Health-related quality of life in female long-term colorectal cancer survivors. Oncologist. 2003;8(4):342–9.CrossRefPubMed
84.
van de Poll-Franse LV, Kwan L, Reiter RE, Lee SP, Litwin MS. The influence of cardiovascular disease on health related quality of life in men with prostate cancer: a 4-year followup study. J Urol. 2008;179(4):1362–7. discussion 1367.CrossRefPubMed
85.
Perkins HY, Baum GP, Taylor CL, Basen-Engquist KM. Effects of treatment factors, comorbidities and health-related quality of life on self-efficacy for physical activity in cancer survivors. Psychooncology. 2009;18(4):405–11.CrossRefPubMed
86.
Edgington A, Morgan MA. Looking beyond recurrence: comorbidities in cancer survivors. Clin J Oncol Nurs. 2011;15(1):E3–E12.CrossRefPubMed
87.
88.
Weaver LC, Jessup A, Mayer DK. Cancer survivorship care: implications for primary care advanced practice nurses. Nurse Pract. 2013;38(11):1–11.CrossRefPubMed
89.
Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Wolff AC, et al. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol. 2013;31(9):1140–8.PubMedCentralCrossRefPubMed
90.
Hickish T, Astras G, Thomas P, Penfold S, Purandare L, Hickish TF, et al. Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst. 2009;101(7):537.CrossRefPubMed
91.
Nguyen NP, Vos P, Vinh-Hung V, Borok TL, Dutta S, Karlsson U, et al. Altered glucose metabolism during chemoradiation for head and neck cancer. Anticancer Res. 2009;29(11):4683–7.PubMed
Metadata
Title
Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009–2010
Authors
Heather P. Tarleton
Suzanne Ryan-Ibarra
Marta Induni
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 3/2014
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0350-x

Other articles of this Issue 3/2014

Journal of Cancer Survivorship 3/2014 Go to the issue

OriginalPaper

Social Networking Site Usage among Childhood Cancer Survivors—A Potential Tool for Research Recruitment?

OriginalPaper

Determinants of newly diagnosed comorbidities among breast cancer survivors

OriginalPaper

Validating the content of a brief informational intervention to empower patients and spouses facing breast cancer: perspectives of both couple members

Review

Psychosocial interventions to support partners of men with prostate cancer: a systematic and critical review of the literature

OriginalPaper

Health behaviors among breast, prostate, and colorectal cancer survivors: a US population-based case-control study, with comparisons by cancer type and gender

OriginalPaper

Predictors of successful use of a web-based healthcare document storage and sharing system for pediatric cancer survivors: Cancer SurvivorLinkTM
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits